Capsimax Capsicum Extract Obtains Self-Affirmed GRAS Notification

OmniActive’s Capsimax Capsicum Extract has received self-affirmed GRAS (Generally Recognized as Safe) notification by an expert panel who evaluated the ingredient in accordance with stringent US Food and Drug Administration (FDA) safety criteria.

“As part of OmniActive’s continued dedication in delivering innovative, effective and safe ingredients to the marketplace, we have invested and focused a tremendous amount of our efforts on Capsimax,” said Lynda M. Doyle, Sr. VP of Global Marketing, OmniActive. “Capsimax is a category-creating ingredient. And with new Capsimax science coming out of our robust clinical program, as well gaining GRAS self-affirmation, Capsimax remains a unique ingredient for sports nutrition, weight management and healthy, active lifestyles.” 

Award-winning Capsimax Capsicum Extract delivers effective levels of capsacinoinds without the oral and gastric burning sensation of unprotected red hot peppers. Capsimax is manufactured using OmniBead Beadlet Technology to encapsulate the beneficial heat of concentrated, highly-active natural capsicum in a controlled release coating.Capsacinoids are backed by more than 90 human clinical studies, and Capsimax supports the mobilization of fats for energy production.


About OmniActive Health Technologies

OmniActive Health Technologies ( offers a range of quality ingredients that are innovative and scientifically validated to address complex challenges for customers in the dietary supplement, food and beverage space using technology-driven, sustainable solutions with application support within a global regulatory framework. OmniActive’s core products include carotenoids, plant extracts and specialty functional ingredients. The company develops IP-protected, science-backed branded ingredients from natural sources using cutting edge technologies. OmniActive leverages international R&D strengths to deploy an array of state of the art manufacturing technologies in extraction, purification, isolation and delivery of nutritional actives. Clinical research geared towards demonstrating efficacy and claim substantiation is the cornerstone of OmniActive’s R&D activities. The company’s centers of excellence are located in North America and India, whereas its cGMP and HACCP system-compliant manufacturing operations are located at multiple FDA inspected sites in India. Whether looking for a new ingredient to add to a finished product, or technology to enhance an existing ingredient, OmniActive delivers unmatched innovation.

Capsimax is a trademark of OmniActive Health Technologies Ltd.